At the news
? NEUTRALIMPACT 3/10 SC 13G/A filed Nov 12, 2026 at 13:02 ET
Daniel Kaufman filed an amended Schedule 13G disclosing a 7.3% passive stake in Abeona Therapeutics as of September 30, 2026. The filing is an amendment to a prior 13G, indicating Kaufman's stake increased from a previously undisclosed level. The passive nature and lack of activist intent make this a routine update.
- Daniel Kaufman reported beneficial ownership of 4,159,099 shares of Abeona Therapeutics common stock as of September 30, 2026.
- The stake represents 7.3% of shares outstanding.
- The filing is an amendment to a prior Schedule 13G, indicating a change in position.
- Kaufman certifies the shares were not acquired with the purpose of changing or influencing control of the issuer.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access